Skip to main content
. 2015 Jan 27;59(2):772–781. doi: 10.1128/AAC.02663-14

FIG 1.

FIG 1

Chemical structure of oritavancin (A), chloroeremomycin (B), and the glycopeptide backbone (C). The hydrophobic 4′-chlorobiphenyl methyl moiety and the 4-epi-vancosamine substituent are highlighted. The leucyl residue missing in des-N-methylleucyl-oritavancin is marked by a dashed circle. Hydrogen bonds are marked by dashed lines.